Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
9/13/2025
CDE Seeks Public Opinions on New HIV/AIDS Drug Guidelines
9/13/2025
CDE Releases New, Comprehensive Guidelines for Innovative Drug Trial A...
9/13/2025
CDE Introduces New Risk Management Guidelines for Innovative Drugs
9/13/2025
CDE Releases First Technical Guidelines for GLP-1 Drugs
9/13/2025
NMPA Releases 96th Batch of Reference Formulations for Generic Drug Ev...
9/12/2025
China NMPA Drastically Shortens Drug Trial Review Times with New Polic...
9/12/2025
CDE Seeks Feedback on Draft Guidance for Post-Approval Changes in Biol...
9/12/2025
CDE Solicits Input on Draft Guidance for Chronic Rhinosinusitis with N...
9/12/2025
CDE Seeks Feedback on Draft Guidance for Depression Drug Clinical Tria...
9/12/2025
CDE Solicits Comments on Draft Guidance for Insomnia Drug Clinical Tri...
9/12/2025
U.S. House Passes Bill That Could Sever Much of U.S.-China Academic Re...
9/9/2025
China's NMPA Seeks Public Feedback on Draft Guidelines for Online Pres...
9/8/2025
CDE Opens Public Consultation on Draft Guidelines for Clinical Trials ...
9/8/2025
CDE Invites Feedback on Draft Guidelines for Clinical Trials of Target...
9/8/2025
CDE Seeks Comments on Draft Guidelines for Clinical Trials of Anti-Fib...
9/8/2025
CDE Solicits Comments on Draft Guidelines for Type I Meetings on Advan...
9/8/2025
CDE Opens Public Consultation on Draft Guidelines for Type I Meetings ...
9/8/2025
CDE Seeks Comments on Draft Technical Guidelines for Chemically Synthe...
9/8/2025
CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...
9/8/2025
CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...
9/8/2025
CDE Issues Technical Guidelines for Clinical Pharmacology Research on ...
9/8/2025
NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...
9/4/2025
CDE Seeks Comments on Draft Guidelines for Pan-Cancer Drug Development
8/29/2025
CDE Issues Draft Requirements for Module 2 Chemistry Doc...
8/29/2025
CDE Issues Technical Guideline for Non-Clinical Research of Vaccine Ad...
8/29/2025
CDE Invites Public Comment on 97th Batch of Reference Formulations for...
8/29/2025
CDE Solicits Comments on Draft Guideline for Post-Approval Change Mana...
8/29/2025
CDE Seeks Comment on ICH E6(R3) GCP Implementation Recommendations
8/21/2025
NMPA Lifts Import Suspension on Vasudha's Loratadine API
8/21/2025
China Proposes Conflict-of-Interest Declarations for Drug Clinical Tri...
Page:
1
/
8
Total number of articles:
212
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit